Leap Therapeutics: A Buy On Near-Term Data Catalysts In Stomach And Colon Cancer

Group 1 - Leap Therapeutics is a precision medicine developer focusing on novel targets for managing solid tumors [1] - The company's main drug is currently undergoing multiple mid-stage clinical tests as an add-on to approved therapies [1] Group 2 - The author has a PhD in biochemistry and extensive experience analyzing clinical trials and biotech companies [1] - The mission is to educate investors on the science behind biotech businesses to aid in due diligence [1]